Jaha Zoda, CEO of BNC Global, speaks during an interview with The Korea Times at the company's headquarters in Songdo, Incheon, Aug. 2. Korea Times photo by Choi Won-suk CEO to launch R&D, manufacturing plant in Hwaseong By Ko Dong-hwan SONGDO, Incheon — BNC Global is on its way to becoming a fully capable local manufacturer of aesthetic medical devices in Korea, as the company aims to broaden its global market for those seeking to improve their natural beauty.
Jaha Zoda, CEO of the Incheon-based company specializing in aesthetic medical products, said that with its new manufacturing facility expected to begin operation early next year in Hwaseong, Gyeonggi Province, his company will no longer remain an exporter and distributor of aesthetic medical products such as dermal fillers, botulinum toxin, skin boosters and lifting threads. He acquired a semiconductor plant in the area and converted it into the company's first manufacturing factory, which will also serve as a research and development center. “Our new factory will adhere to pharmaceutical grade standards which are much stricter than those of medical device grade,” the CEO said in his interview with The Korea Times at his company’s head office in Incheon.
“Although fillers are classified as medical devices, we will enhance their safety and ensure they meet the current Good Manufacturing Practice standards.” The BNC Global's booth is set up during Dubai Derma 2024 in March. Courtesy of BNC Global Dermal fille.